WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2017

Feb 16, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2017-02-14

Reporting Person: Green Eric Mark (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-14	Common Stock	A	1540.00	$86.93	Acquired	53231.0865	Direct
2017-02-14	Common Stock	A	6225.00	$86.93	Acquired	59456.0865	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	248.7748	Indirect

Footnotes

F1: Bonus and incentive shares granted on 02/14/2017.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.

F3: Shares represent the portion of the Performance Share Unit Award granted in 2014 that have vested for period 13.